Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® .
Clinical trial NCT04591275 · COMPLETED
Trial details
- NCT number
- NCT04591275
- Sponsor
- Shanghai Biomabs Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2024-11-01
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.